CDO1 and neoplasm: Decreased CDO1 activity may support tumor cell growth by reducing reactive oxygen species and decreasing drug susceptibility (Kang et al., 2019; Jeschke et al., 2013; Hao et al., 2017; Ma et al., 2022).